Henoch-schönlein Purpura (HSP) in a patient on Abemaciclib

by Claudia Omarini, Eleonora Molinaro, Monica Barbolini, Massimo Dominici, Federico Piacentini
Published 2020-08-01

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?

by Angela Toss, Marta Venturelli, Chiara Peterle, Federico Piacentini, Stefano Cascinu, Laura Cortesi
Published 2017-01-01

The Role of Exosomes in Breast Cancer Diagnosis

by Claudia Piombino, Ilenia Mastrolia, Claudia Omarini, Olivia Candini, Massimo Dominici, Federico Piacentini, Angela Toss
Published 2021-03-01

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review

by Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, Rita Balsano, Federico Piacentini, Massimo Dominici, Fabio Gelsomino
Published 2021-01-01

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to presc...

by Claudia Omarini, Federico Piacentini, Isabella Sperduti, Monica Barbolini, Chrystel Isca, Angela Toss, Laura Cortesi, Elena Barbieri, Massimo Dominici, Luca Moscetti
Published 2020-05-01

Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy

by Claudia Omarini, Stefania Bettelli, Samantha Manfredini, Monica Barbolini, Chrystel Isca, Giulia Cortesi, Antonino Maiorana, Giovanni Tazzioli, Massimo Dominici, Federico Piacentini
Published 2020-09-01

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

by Claudia Omarini, Maria Elisabetta Filieri, Stefania Bettelli, Samantha Manfredini, Shaniko Kaleci, Cecilia Caprera, Cecilia Nasso, Monica Barbolini, Giorgia Guaitoli, Luca Moscetti, Antonino Maiorana, Pier Franco Conte, Stefano Cascinu, Federico Piacentini
Published 2018-01-01

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer

by Gaia Griguolo, Maria Vittoria Dieci, Laia Paré, Federica Miglietta, Daniele Giulio Generali, Antonio Frassoldati, Luigi Cavanna, Giancarlo Bisagni, Federico Piacentini, Enrico Tagliafico, Katia Cagossi, Guido Ficarra, Aleix Prat, Pierfranco Conte, Valentina Guarneri
Published 2021-02-01

The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Exper...

by Margherita Rimini, Annarita Pecchi, Francesco Prampolini, Chiara Bussei, Massimiliano Salati, Daniela Forni, Francesca Martelli, Filippo Valoriani, Fabio Canino, Alessandro Bocconi, Fabio Gelsomino, Linda Reverberi, Stefania Benatti, Federico Piacentini, Renata Menozzi, Massimo Dominici, Gabriele Luppi, Andrea Spallanzani
Published 2021-04-01

Immune characterization of breast cancer metastases: prognostic implications

by Maria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto, Federico Piacentini, Guido Ficarra, Gaia Griguolo, Federica Miglietta, Tommaso Giarratano, Claudia Omarini, Serena Bonaguro, Rocco Cappellesso, Camillo Aliberti, Grazia Vernaci, Carlo Alberto Giorgi, Giovanni Faggioni, Giulia Tasca, Pierfranco Conte, Valentina Guarneri
Published 2018-06-01

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

by Maria Vittoria Dieci, Giancarlo Bisagni, Alba A. Brandes, Antonio Frassoldati, Luigi Cavanna, Francesco Giotta, Michele Aieta, Vittorio Gebbia, Antonino Musolino, Ornella Garrone, Michela Donadio, Anita Rimanti, Alessandra Beano, Claudio Zamagni, Hector Soto Parra, Federico Piacentini, Saverio Danese, Antonella Ferro, Katia Cagossi, Samanta Sarti, Anna Rita Gambaro, Sante Romito, Viviana Bazan, Laura Amaducci, Gabriella Moretti, Maria Pia Foschini, Sara Balduzzi, Roberto Vicini, Roberto D’Amico, Gaia Griguolo, Valentina Guarneri, Pier Franco Conte
Published 2019-11-01